Twill Care
Commercial- Indications
- Multiple chronic conditions
Company intelligence / Profile preview
Twill has demonstrated improved patient outcomes such as a 20% higher rate of medication adherence among users. Its platform produces robust clinical outcome and health economic data through randomized controlled trials, real-world evidence studies, and insurance claims-based validation. Commercial partnerships have reported up to a 10:1 ROI using the platform. Programs are live for mental health, MS, pregnancy/women’s health, psoriasis; new conditions can be rapidly added.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twill.